Galapagos NV
GLPG
#4542
Rank
NZ$3.62 B
Marketcap
NZ$54.94
Share price
-1.60%
Change (1 day)
22.54%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -NZ$0.92 Billion

According to Galapagos NV's latest financial reports the company's current earnings are NZ$0.32 Billion. In 2024 the company made an earning of -NZ$9.92 Million, an increase over its 2023 earnings that were of -NZ$57.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.92 Billion9113.11%
2024 -NZ$9.92 Million-82.77%
2023 -NZ$57.57 Million-85.59%
2022 -NZ$0.4 Billion60.71%
2021 -NZ$0.25 Billion-60.08%
2020 -NZ$0.63 Billion-331.44%
2019 NZ$0.26 B-523.76%
2018 -NZ$63.51 Million-72.34%
2017 -NZ$0.23 Billion-329.59%
2016 NZ$0.10 B-144.3%
2015 -NZ$0.23 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$55.60 B-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.96 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.84 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.61 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$39.62 B-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$22.46 B-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$16.00 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-NZ$91.78 Million-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.69 B-504.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel